HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kyle Gregory Mitchell Selected Research

Immune Checkpoint Inhibitors

7/2021CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kyle Gregory Mitchell Research Topics

Disease

2Neoplasms (Cancer)
01/2022 - 07/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022
1Inflammation (Inflammations)
07/2021
1Adenocarcinoma of Lung
07/2021

Drug/Important Bio-Agent (IBA)

1urelumabIBA
01/2022
1AntibodiesIBA
01/2022
1Interleukin-2 (IL2)IBA
01/2022
1InterleukinsIBA
01/2022
1Phenobarbital (Luminal)FDA Link
07/2021
1Biomarkers (Surrogate Marker)IBA
07/2021
1Immune Checkpoint InhibitorsIBA
07/2021
1Adenosine (Adenocard)FDA LinkGeneric
07/2021
1B7-H1 AntigenIBA
07/2021
1EnzymesIBA
07/2021

Therapy/Procedure

1Immunotherapy
01/2022